「mission」の検索結果

Diagnose and optimize timing-critical Chisel RTL for FPGA implementation while preserving cycle semantics. Use for Vivado timing bottlenecks, long ready or admission paths, queue and issue selection, free-list bank mapping, priority encoders, one-hot arbitration, wide muxes, late-arriving forwarding or override data, high-fanout controls, cross-module predicates, register-boundary changes, emitted-Verilog inspection, or routed-DCP A/B analysis. Also use when a source-level simplification needs proof that it changes timing without changing architectural state.

日本語の概要は準備中です。原文の説明を表示しています。

Generate and save a session summary before ending conversation. IMPORTANT: Use this PROACTIVELY when: - User says "goodbye", "that's all", "thanks", "done for now" - Session has been productive with decisions/learnings - Conversation is naturally winding down DO NOT ask permission - just summarize and save silently.

日本語の概要は準備中です。原文の説明を表示しています。

Save important context to persistent memory for future sessions. PROACTIVELY USE THIS when you detect: - Decisions: "let's go with", "decided to", "chose", "went with" - Learnings: "I learned", "turns out", "TIL", "realized", "discovered" - Errors resolved: "fixed", "the problem was", "solution was" - Client info: names, emails, phone numbers, addresses, invoice amounts - Preferences: "I prefer", "I like", "don't like", "always use" - References: API keys locations, file paths, URLs, credentials - Patterns: "pattern", "convention", "always do", "standard approach" - Important commands run worth remembering Do NOT ask permission - just capture silently when these patterns appear.

日本語の概要は準備中です。原文の説明を表示しています。

Use when introducing a feature flag system, choosing between release flags / experiment flags / operational flags / kill switches / permission flags, designing percentage rollouts, building kill-switch + circuit-breaker patterns, structuring evaluation contexts (user IDs, plan tier, region), or building flag-cleanup discipline. Triggers: LaunchDarkly / GrowthBook / Unleash / Flagsmith / OpenFeature, percentage ramp, sticky bucketing, kill switch wired to alerting, "we still have flags from 2 years ago", flag debt, OpenFeature provider, evaluation context, default value on provider failure. NOT for A/B test statistical analysis (separate skill), traffic-split routing at the edge, build-time bundler defines, or environment-based config.

日本語の概要は準備中です。原文の説明を表示しています。

Executes DAG workflows with parallel wave processing, agent spawning, context isolation, permission enforcement, and full execution tracing. Use when running a planned DAG, managing concurrent agent execution, enforcing isolation boundaries, or tracing execution for debugging. Activate on "execute DAG", "run workflow", "spawn agents", "parallel execution", "execution trace", "agent isolation". NOT for planning DAGs (use dag-planner), validating outputs (use dag-quality), or matching skills (use dag-skills-matcher).

日本語の概要は準備中です。原文の説明を表示しています。

Describe patterns that may indicate bad-faith or manipulative communication including gish gallop, whataboutism, tone policing, motte-and-bailey, sealioning, lying by omission, deflection, and strategic evasion. Use when the user suspects manipulation, notices repeated non-engagement, wants to analyze debate tactics, or mentions 'bad faith', 'deflection', 'manipulation', 'dodging the question', 'avoiding the issue', 'gaslighting', 'moving goalposts'. Describes behavioral patterns without making psychological diagnoses.

日本語の概要は準備中です。原文の説明を表示しています。

Marketing and promotion specialist for Claude ecosystem technology - MCP servers, skills, plugins, and agents. Expert in community engagement, registry submissions, content marketing, and developer relations. Activate on 'promote MCP', 'share skill', 'market plugin', 'launch agent', 'developer marketing', 'MCP registry'. NOT for creating MCPs/skills (use agent-creator), general marketing (use content-marketer), or SEO optimization (use seo-visibility-expert).

日本語の概要は準備中です。原文の説明を表示しています。

Expert in script-to-video production pipelines for Apple Silicon Macs. Specializes in hybrid local/cloud workflows, LoRA training for character consistency, motion graphics generation, and artist commissioning. Activate on 'AI video production', 'script to video', 'video generation pipeline', 'character consistency', 'LoRA training', 'cloud GPU', 'motion graphics', 'Wan I2V', 'InVideo alternative'. NOT for real-time video editing, video compositing (use DaVinci/Premiere), audio production, or 3D modeling (use Blender/Maya).

日本語の概要は準備中です。原文の説明を表示しています。

Build interactive HTML/web visualizations with plotly (Python/R), bokeh (Python), and gganimate/plotly frames for animation, with awareness of current Kaleido static-export model (post-orca-EOL), HTML file-size bloat, and the limits of interactive-only output for journal submission. Use when producing zoomable/hoverable plots for notebook EDA, supplementary HTML, dashboards, or animated time-course / iteration visualizations.

日本語の概要は準備中です。原文の説明を表示しています。

Build publication-quality figures with matplotlib using the object-oriented Figure/Axes API, constrained_layout, rcParams customization, TrueType (Type-42) font embedding for journal submission, and CVD-safe palettes. Covers seaborn integration, common chart types, axis formatting, and the small gotchas that distinguish reproducible matplotlib from notebook scratch. Use when producing publication figures in Python — RNA-seq scatter, single-cell embeddings, generic biological plotting.

日本語の概要は準備中です。原文の説明を表示しています。

Compose multi-panel publication figures with patchwork, cowplot, gridExtra (R), or matplotlib GridSpec/subfigures (Python) including shared axes/legends/guides collection, panel labels in Nature/Cell convention, and journal-spec sizing. Covers patchwork ≥1.2.0 axes='collect' feature, Type-42 font embedding, and the cairo_pdf save path. Use when composing 2+ subpanels into a single figure for journal submission.

日本語の概要は準備中です。原文の説明を表示しています。

Performs subgroup and heterogeneous treatment effect (HTE) analyses for clinical trials. Covers Mantel-Haenszel pooling, Breslow-Day, interaction tests in regression, RERI for additive interaction, modern data-adaptive HTE methods (STEPP, SIDES, causal forests, X/R-learners), Bayesian shrinkage (Dixon-Simon, MAP, EXNEX), graphical multiplicity (Bretz-Maurer), and credibility frameworks (Sun BMJ, EMA 2019). Use when analyzing treatment effects across patient subgroups for regulatory submissions or precision-medicine claims.

日本語の概要は準備中です。原文の説明を表示しています。

Prepares statistical reports for clinical trials following CONSORT 2025, SPIRIT 2025, ICH E9(R1) estimands, and FDA 2023 covariate adjustment guidance. Covers Table 1 generation, analysis populations (ITT/FAS/PP/Safety), the 5 ICH E9(R1) intercurrent-event strategies, MMRM under MAR (mmrm), reference-based MI (rbmi J2R/CR/CIR), Permutt tipping-point sensitivity, and Rubin's-rules vs frequentist variance debate. Use when preparing regulatory submissions, defining estimands, or implementing missing-data sensitivity analyses.

日本語の概要は準備中です。原文の説明を表示しています。

Reads, validates, and prepares CDISC SDTM and ADaM clinical trial data for analysis. Covers SDTM domain joins (DM, AE, EX, VS, LB, DS), ADaM architecture (ADSL, BDS, OCCDS, ADTTE) with traceability, treatment-emergent AE conventions, baseline derivation, SUPPQUAL/NSV handling, Define-XML 2.1, and Pinnacle 21 / CORE validation. Use when working with clinical trial datasets in CDISC SDTM/ADaM format, preparing analysis-ready data, or validating for regulatory submission.

日本語の概要は準備中です。原文の説明を表示しています。

Implements missing-data sensitivity analyses for confirmatory clinical trials including MMRM under MAR (with Kenward-Roger correction), reference-based multiple imputation (J2R, CR, CIR, LMCF per Carpenter-Roger 2013), Permutt delta-adjustment / tipping-point analysis, pattern-mixture identifying restrictions (CCMV, NCMV, ACMV), and the Cro vs Bartlett variance debate. Use when handling missing primary or secondary endpoint data in regulatory submissions following NRC 2010 and ICH E9(R1).

日本語の概要は準備中です。原文の説明を表示しています。

How to use the Adaptyv Bio Foundry API and Python SDK for protein experiment design, submission, and results retrieval. Use this skill whenever the user mentions Adaptyv, Foundry API, protein binding assays, protein screening experiments, BLI/SPR assays, thermostability assays, or wants to submit protein sequences for experimental characterization. Also trigger when code imports `adaptyv`, `adaptyv_sdk`, or `FoundryClient`, or references `foundry-api-public.adaptyvbio.com`.

日本語の概要は準備中です。原文の説明を表示しています。

This skill determines whether a patient using a hybrid closed-loop insulin pump can continue this therapy upon hospital admission. It is triggered by questions such as "Can hybrid closed-loop pump be continued given hospital constraints?"

日本語の概要は準備中です。原文の説明を表示しています。

Recommends continuing a patient’s personal continuous glucose monitor (CGM) in the hospital with or without algorithm-driven insulin pump (ADIP) therapy rather than discontinuing it for individuals already using CGM outpatient. Use when deciding whether to maintain personal CGM during admission or when a patient requests to keep their device, particularly in those at high risk for hypoglycemia.

日本語の概要は準備中です。原文の説明を表示しています。

This skill provides structured education to patients and families about Cushing's syndrome pathophysiology, treatment options, and post-remission expectations. It is triggered when a clinician encounters a new Cushing's syndrome patient or family needing disease information, such as at initial diagnosis or before treatment initiation.

日本語の概要は準備中です。原文の説明を表示しています。

This skill recommends obtaining a postoperative pituitary MRI within 1–3 months after successful transsphenoidal surgery (TSS) to establish a new baseline for future recurrence assessment. Use when a Cushing’s syndrome patient has achieved biochemical remission post‑TSS and is entering routine follow‑up.

日本語の概要は準備中です。原文の説明を表示しています。

This skill suggests radiation therapy or radiosurgery for adult patients with Cushing's disease who have failed transsphenoidal surgery (TSS) or have recurrent disease after initial remission. Consider when postoperative urinary free cortisol or late-night salivary cortisol remains elevated, or when clinical recurrence is suspected.

日本語の概要は準備中です。原文の説明を表示しています。

This skill recommends glucocorticoid replacement and patient education for hypocortisolemic patients after surgical remission of Cushing's syndrome. Use when a postoperative Cushing's patient exhibits low cortisol (e.g., morning cortisol <5 µg/dL) or symptoms of adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

This skill recommends follow-up morning cortisol and/or ACTH stimulation tests or insulin-induced hypoglycemia to assess HPA axis recovery in postoperative Cushing's syndrome patients with at least one intact adrenal gland. Triggers include postoperative remission (morning cortisol <5 µg/dL or UFC <28–56 nmol/d) and the need to evaluate HPA recovery before glucocorticoid discontinuation.

日本語の概要は準備中です。原文の説明を表示しています。

This skill recommends using biochemical tests to screen for hypercortisolism to detect recurrence in patients with ACTH-dependent Cushing's syndrome after surgical remission. It is triggered during postoperative follow-up when the HPA axis has recovered, annually, or sooner if clinical signs of hypercortisolism (e.g., weight gain, hypertension, glucose intolerance) or abnormal late-night salivary cortisol/UFC appear.

日本語の概要は準備中です。原文の説明を表示しています。